S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)

PetMed Express - PETS Stock Forecast, Price & News

$23.56
+0.04 (+0.17%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$23.11
$24.01
50-Day Range
$19.64
$23.56
52-Week Range
$19.08
$32.67
Volume
533,202 shs
Average Volume
427,499 shs
Market Capitalization
$494.50 million
P/E Ratio
24.54
Dividend Yield
5.10%
Price Target
$26.33

PetMed Express MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
11.8% Upside
$26.33 Price Target
Short Interest
Bearish
29.89% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
7.69%
From $0.91 to $0.98 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars

Retail/Wholesale Sector

132nd out of 218 stocks

Drug Stores & Proprietary Stores Industry

4th out of 6 stocks

PETS stock logo

About PetMed Express (NASDAQ:PETS) Stock

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Analysts Set New Price Targets

Separately, Morgan Stanley reduced their target price on PetMed Express from $20.00 to $19.00 and set an "underweight" rating for the company in a research report on Tuesday, July 26th.

PetMed Express Stock Performance

Shares of NASDAQ:PETS traded down $0.31 during midday trading on Wednesday, reaching $23.21. 11,107 shares of the company traded hands, compared to its average volume of 467,043. The firm has a market cap of $487.18 million, a PE ratio of 24.50 and a beta of 0.59. The stock's 50-day simple moving average is $21.46 and its 200-day simple moving average is $23.46. PetMed Express has a 12 month low of $19.08 and a 12 month high of $32.67.

PetMed Express (NASDAQ:PETS - Get Rating) last issued its quarterly earnings data on Monday, July 25th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.11). PetMed Express had a net margin of 7.36% and a return on equity of 13.77%. During the same period in the prior year, the firm earned $0.26 EPS. On average, equities research analysts expect that PetMed Express will post 0.91 EPS for the current year.

PetMed Express Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 19th. Investors of record on Friday, August 12th will be issued a $0.30 dividend. The ex-dividend date is Thursday, August 11th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.17%. PetMed Express's dividend payout ratio is 125.00%.

Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Stock News Headlines

PetMed Express (NASDAQ:PETS) PT Lowered to $19.00
Petmed Express Shares Plunge On Q1 Earnings Miss
PetMed Express Inc - Stock Ownership PETS
Best Pet Insurance In New Jersey 2022
PetMed Express, Inc. (PETS)
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

PETS Company Calendar

Ex-Dividend for 5/27 Dividend
5/19/2022
Dividend Payable
5/27/2022
Last Earnings
7/25/2022
Ex-Dividend for 8/19 Dividend
8/11/2022
Today
8/17/2022
Dividend Payable
8/19/2022
Next Earnings (Estimated)
10/24/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
219
Year Founded
1996

Price Target and Rating

Average Stock Price Forecast
$26.33
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$19.00
Forecasted Upside/Downside
+11.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$21.10 million
Pretax Margin
9.49%

Debt

Sales & Book Value

Annual Sales
$273.42 million
Cash Flow
$1.21 per share
Book Value
$6.68 per share

Miscellaneous

Free Float
20,128,000
Market Cap
$494.50 million
Optionable
Optionable
Beta
0.59

Social Links















PETS Stock - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings
or view top-rated stocks.

What is PetMed Express' stock price forecast for 2022?

3 Wall Street analysts have issued twelve-month price targets for PetMed Express' stock. Their PETS share price forecasts range from $19.00 to $32.00. On average, they predict the company's share price to reach $26.33 in the next twelve months. This suggests a possible upside of 11.8% from the stock's current price.
View analysts price targets for PETS
or view top-rated stocks among Wall Street analysts.

How have PETS shares performed in 2022?

PetMed Express' stock was trading at $25.26 at the beginning of 2022. Since then, PETS stock has decreased by 6.7% and is now trading at $23.56.
View the best growth stocks for 2022 here
.

When is PetMed Express' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 24th 2022.
View our PETS earnings forecast
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings results on Monday, July, 25th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.25 by $0.11. PetMed Express had a net margin of 7.36% and a trailing twelve-month return on equity of 13.77%. During the same quarter in the prior year, the business earned $0.26 EPS.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express announced a quarterly dividend on Monday, July 25th. Shareholders of record on Friday, August 12th will be paid a dividend of $0.30 per share on Friday, August 19th. This represents a $1.20 annualized dividend and a dividend yield of 5.09%. The ex-dividend date of this dividend is Thursday, August 11th.
Read our dividend analysis for PETS
.

Is PetMed Express a good dividend stock?

PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 5.10%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 122.45% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for PETS.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

What is PetMed Express' stock symbol?

PetMed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (5.61%), State Street Corp (4.77%), ProShare Advisors LLC (3.77%), Personal Capital Advisors Corp (2.07%), Millennium Management LLC (1.20%) and Northern Trust Corp (1.07%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetMed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $23.56.

How much money does PetMed Express make?

PetMed Express (NASDAQ:PETS) has a market capitalization of $494.50 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.96 on an earnings per share basis.

How many employees does PetMed Express have?

The company employs 219 workers across the globe.

When was PetMed Express founded?

PetMed Express was founded in 1996.

How can I contact PetMed Express?

PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445.

This page (NASDAQ:PETS) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.